Žádné připojení k internetu — zobrazuje se uložená verze stránky.

Grifols S.A

USUSD
← Do Screeneru

Grifols S.A (LSE:0RDU) — Drug Manufacturers - General. Počet burz, na kterých se obchodují akcie společnosti: 4. Na této stránce — cena a graf, dividendy, největší akcionáři a historie počtu akcií.

⚠ Nepleťte si to: existuje jiná společnost se stejným nebo velmi podobným názvem. Toto je samostatný záznam — zkontrolujte ticker, burzu a registrační číslo.
  • Grifols SA — GRF-P · MC ES Registrační číslo neznámé

O Společnosti

Web
grifols.com
Vztahy s Investory
grifols.com/en/investors
Sektor
Healthcare · Drug Manufacturers - General
Sídlo
NEW YORK, Spain
Generální Ředitel
Jose Ignacio Abia Buenache
Zaměstnanci
25 258
Založena
1909
Na Burze od
23.11.2007 (LSE:0RDU)
Akcie v Oběhu
422.36 mil.
Volně Obchodovatelné Akcie
418.2 mil.
Tržní Kapitalizace
7.57 mld. USD
Insideři
31.19%
Instituce
37.75%
Odvětví (SIC)
Pharmaceutical Preparations
Právní Forma
5RDO
ISIN
ES0171996012
LEI
959800HSSNXWRKBK4N60
Výplatní Poměr
≈7.7%
FCF
641 mil. EUR
Výplata / FCF
5%
Dluh
8.52 mld. EUR
11 r. FCF
Dividendová Řada
1 r.
Zisk, FCF a vyplacené dividendy — za 12 měsíců do 30.06.2026 (poslední zpráva společnosti).
Popis

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.

reklama

Burzy a Tickery

BurzaTickerMěnaCenaTyp
US USA StocksGIFLF OTCUSD10.547 -5.24%kmenové akcie
LSE London Stock Exchange0RDU IOBEUR16.125 +0.00%kmenové akcie
MC Bolsa de MadridGRF hlavníEUR9.8 +1.43%kmenové akcie
VI Vienna Stock ExchangeGRF doplňkováEUR9.962 +0.99%kmenové akcie

Cena za 3 Měsíce

den růstu den poklesu ex-dividendový den den výplatyNajeďte / klepněte na den — otevírací, závěrečná, nejvyšší a nejnižší cena

Dividendy

Grifols S.A (GIFLF) vyplácí dividendy jednou ročně.

Ex-Dividendový DenVýplataČástka%TypTicker
2026-07-012026-07-020.0824 EUR0.9 %mimořádnáUS:GIFLF
2025-08-122025-08-130.1500 EUR1.2 %mimořádnáUS:GIFLF

Největší Držitelé

DržitelPodílAkcieDatum Zprávy
VANGUARD STAR FUNDS-Vang…1%4.28 mil.2026-04-30
VANGUARD TAX-MANAGED FUN…0.66%2.8 mil.2026-06-30
iShares Trust-iShares Co…0.49%2.08 mil.2026-07-31
DFA INVESTMENT DIMENSION…0.34%1.46 mil.2026-04-30
Dimensional ETF Trust-Di…0.25%1.07 mil.2026-04-30
iShares Trust-iShares MS…0.22%935 1282026-07-31
DFA INVESTMENT TRUST CO-…0.17%741 7722026-04-30
VANGUARD Intl Eqy. INDEX…0.16%696 5102026-04-30
SCHWAB STRATEGIC TRUST-S…0.16%676 4822026-05-31
VANGUARD Intl Eqy. INDEX…0.15%634 2982026-04-30
Pacer Advisors, Inc.0%1 3232026-06-30